New Delhi: Pfizer will seek authorisation from the US for the third dose of its COVID-19 vaccine. It said on Thursday that another jab in a year’s time could boost ...
New Delhi: AstraZeneca joins other vaccines that are effective against the Delta variant. COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian ...
New Delhi: American pharmaceutical companies Pfizer and Moderna are in talks with the Centre over their COVID-19 vaccines, Niti Aayog member (health) Dr VK Paul said. “Approval to Pfizer and ...
Pfizer will launch a large study to test its COVID-19 vaccine for children below 12. The company said on Tuesday that it has selected a dosing regime for the trial, ...
New Delhi: Moderna is likely to introduce a single-dose COVID-19 vaccine in India in 2022 while another US giant Pfizer will offer 5 crore jabs in 2021. At a time ...
New Delhi: A study by Public Health England (PHE) has found both Oxford-AstraZeneca (Covishield in India) and Pfizer vaccines to be highly effective against the COVID-19 variant first detected in ...
Madrid: Given the shortage of vaccines, especially in a populous country like India, experts have been trying to ascertain whether mixing vaccines is advisable. A study conducted in Spain revealed ...
Tokyo: Pfizer and BioNtech will donate doses of their COVID-19 vaccine to participants at the Olympic and paralympic games that are due here in July. In what is seen as ...
Pfizer has decided to donate medical supplies, including drugs to treat COVID-19 patients, worth $70 million to India. In a statement on Monday, the US pharmaceutical company said it was ...
New York: An oral drug to treat COVID-19, developed by Pfizer, may be ready next year. “We are actually working on two drugs, one is injectable and the other one ...